Palantir's Growth Has Kept Accelerating, but Can the Rally Continue?

Palantir reported Q2 revenue growth of 93%, including 149% growth in U.S. commercial revenue to $764M and 90% growth in U.S. government revenue to $809M, but Wall Street expects growth to slow to 84% in Q3. The company generated a 55% profit margin, yet its valuation of nearly 150x trailing earnings prices in substantial future expansion; earnings would need to rise more than 250% for the P/E to decline to 40x at the current share price. The article argues that slowing commercial customer additions—up 6% quarter over quarter to 653—could pressure the stock if Palantir cannot sustain near-100% growth.

Analysis

The key investable issue is not whether PLTR can beat the next revenue print, but whether incremental growth is increasingly concentrated in spend expansion from existing U.S. accounts rather than broad customer acquisition. That mix can sustain near-term upside, particularly around government awards, but it raises durability risk: a smaller number of large deployments makes quarterly bookings more lumpy and weakens the evidence for a repeatable international commercial sales engine. A deceleration in net-new customer additions would likely matter more to the multiple than a modest revenue beat.

PLTR's valuation leaves little room for the normal maturation of an enterprise software company. With margins already elevated, operating leverage has less capacity to offset slowing sales growth; a growth reset therefore transmits directly into both earnings-estimate reductions and multiple compression. The most relevant 1-3 month catalysts are Q3 commercial customer growth, remaining-deal-value/bookings conversion, and management's 2027 outlook framework. A revenue beat without reacceleration in customers or forward bookings could be sold as evidence that the installed base is being harvested.

Consensus bearishness may be premature if AIP deployments create a delayed land-and-expand cycle: customer-count growth can slow while per-customer spend rises sharply, especially among defense and regulated enterprises. The falsifier for the short thesis is sustained commercial growth above expectations alongside accelerating customer additions and material upward revisions to forward EPS; absent those, PLTR remains vulnerable to a sharp de-rating on merely good results. NVDA is a cleaner AI exposure for investors seeking earnings visibility, while PLTR-specific sentiment deterioration need not imply a broader AI-software unwind.

Key Decisions for Investors

• Maintain a tactical underweight/short PLTR into the next earnings event only after a post-results rally; target a 15-25% drawdown over 1-3 months if commercial customer growth decelerates further or forward revenue expectations fail to rise. Cover if management materially raises full-year guidance and reports renewed sequential acceleration in U.S. commercial customer additions.
• Express relative valuation risk via long NVDA / short PLTR in equal dollar beta-adjusted size over 3-6 months. The pair isolates PLTR's execution-and-multiple risk from broad AI demand; exit if PLTR's forward EPS revisions outperform NVDA's for two consecutive estimate periods.
• Do not add directional PLTR exposure solely on a quarterly revenue beat. Require disclosure of net-new commercial customers, bookings/RDV growth, international traction, and concentration among large accounts before treating upside as structurally investable.
• For existing long PLTR exposure, buy 3-6 month downside protection around earnings rather than selling solely on valuation. A put spread is preferable to outright puts given the plausible upside tail from a major government award or unexpectedly strong AIP expansion.